COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major Trump administration policy shift.

The approach -- using a placebo when a "standard-of-care" vaccine already exists -- is contentious within the biomedical ...

There have been 1,024 confirmed cases of measles across 30 states so far this year, according to the latest update from the ...

The World Health Organisation said on Tuesday that circulating vaccine-derived poliovirus type 2 (cVDPV2) had been detected ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later this ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.